139 related articles for article (PubMed ID: 1362276)
1. Tardive dyskinesia and diabetes mellitus.
Ganzini L; Casey DE; Hoffman WF; Heintz RT
Psychopharmacol Bull; 1992; 28(3):281-6. PubMed ID: 1362276
[TBL] [Abstract][Full Text] [Related]
2. The prevalence of metoclopramide-induced tardive dyskinesia and acute extrapyramidal movement disorders.
Ganzini L; Casey DE; Hoffman WF; McCall AL
Arch Intern Med; 1993 Jun; 153(12):1469-75. PubMed ID: 8512437
[TBL] [Abstract][Full Text] [Related]
3. The current prevalence and factors associated with tardive dyskinesia among Filipino schizophrenic patients.
Go CL; Rosales RL; Caraos RJ; Fernandez HH
Parkinsonism Relat Disord; 2009 Nov; 15(9):655-9. PubMed ID: 19346155
[TBL] [Abstract][Full Text] [Related]
4. A cross-sectional study of parkinsonism and tardive dyskinesia in lithium-treated affective disordered patients.
Ghadirian AM; Annable L; Bélanger MC; Chouinard G
J Clin Psychiatry; 1996 Jan; 57(1):22-8. PubMed ID: 8543543
[TBL] [Abstract][Full Text] [Related]
5. Diabetes is not a risk factor for tardive dyskinesia: a retrospective observational study.
Raja M; Azzoni A
Hum Psychopharmacol; 2002 Jan; 17(1):61-3. PubMed ID: 12404708
[TBL] [Abstract][Full Text] [Related]
6. Tardive dyskinesia in India: a prevalence study.
Doongaji DR; Jeste DV; Jape NM; Sheth AS; Apte JS; Vahia VN; Desai AB; Vahora SA; Thatte S; Vevaina T; Bharadwaj J
J Clin Psychopharmacol; 1982 Oct; 2(5):341-4. PubMed ID: 6127352
[TBL] [Abstract][Full Text] [Related]
7. Risk factors for drug-induced parkinsonism in tardive dyskinesia patients.
Hansen TE; Brown WL; Weigel RM; Casey DE
J Clin Psychiatry; 1988 Apr; 49(4):139-41. PubMed ID: 2895762
[TBL] [Abstract][Full Text] [Related]
8. Serum concentrations of haloperidol pyridinium metabolites and the relationship with tardive dyskinesia and parkinsonism: a cross-section study in psychiatric patients.
Ulrich S; Sandmann U; Genz A
Pharmacopsychiatry; 2005 Jul; 38(4):171-7. PubMed ID: 16025420
[TBL] [Abstract][Full Text] [Related]
9. Predictors of neuroleptic-induced dyskinesia and parkinsonism: the influence of measurement methods and definitions.
Dean CE; Kuskowski MA; Caligiuri MP
J Clin Psychopharmacol; 2006 Dec; 26(6):560-5. PubMed ID: 17110811
[TBL] [Abstract][Full Text] [Related]
10. The natural history of tardive dyskinesia.
Gardos G; Cole JO; Haskell D; Marby D; Paine SS; Moore P
J Clin Psychopharmacol; 1988 Aug; 8(4 Suppl):31S-37S. PubMed ID: 2906068
[TBL] [Abstract][Full Text] [Related]
11. High incidence of tardive dyskinesia in older outpatients on low doses of neuroleptics.
Harris MJ; Panton D; Caligiuri MP; Krull AJ; Tran-Johnson TK; Jeste DV
Psychopharmacol Bull; 1992; 28(1):87-92. PubMed ID: 1609047
[TBL] [Abstract][Full Text] [Related]
12. Buspirone in the treatment of tardive dyskinesia.
Moss LE; Neppe VM; Drevets WC
J Clin Psychopharmacol; 1993 Jun; 13(3):204-9. PubMed ID: 8102622
[TBL] [Abstract][Full Text] [Related]
13. Tardive dyskinesia, mild drug-induced dyskinesia, and drug-induced parkinsonism: risk factors and topographic distribution.
Akbostanci MC; Atbaşoğlu EC; Balaban H
Acta Neurol Belg; 1999 Sep; 99(3):176-81. PubMed ID: 10544725
[TBL] [Abstract][Full Text] [Related]
14. [Epidemiology of tardive dyskinesias in the Maghreb].
Moussaoui D; Douki S; Bentounsi B; Otarid A; Chorfi M; Mamou A; Benamor L
Encephale; 1988 Sep; 14 Spec No():203-8. PubMed ID: 2905647
[TBL] [Abstract][Full Text] [Related]
15. Tardive dyskinesia in outpatients on depot phenothiazine.
Neehall J
West Indian Med J; 1989 Dec; 38(4):228-33. PubMed ID: 2576166
[TBL] [Abstract][Full Text] [Related]
16. Tardive dyskinesia in schizophrenic outpatients: prevalence and significant variables.
Ezrin-Waters C; Seeman MV; Seeman P
J Clin Psychiatry; 1981 Jan; 42(1):16-22. PubMed ID: 6109715
[TBL] [Abstract][Full Text] [Related]
17. The prevalence of tardive dyskinesia in neuroleptic-treated diabetics. A controlled study.
Ganzini L; Heintz RT; Hoffman WF; Casey DE
Arch Gen Psychiatry; 1991 Mar; 48(3):259-63. PubMed ID: 1671743
[TBL] [Abstract][Full Text] [Related]
18. A summary of current knowledge of tardive dyskinesia.
Baldessarini RJ
Encephale; 1988 Sep; 14 Spec No():263-8. PubMed ID: 2905654
[TBL] [Abstract][Full Text] [Related]
19. Predicting the long-term risk of tardive dyskinesia in outpatients maintained on neuroleptic medications.
Glazer WM; Morgenstern H; Doucette JT
J Clin Psychiatry; 1993 Apr; 54(4):133-9. PubMed ID: 8098030
[TBL] [Abstract][Full Text] [Related]
20. Affective disorders and tardive dyskinesia.
Casey DE
Encephale; 1988 Sep; 14 Spec No():221-6. PubMed ID: 2905650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
